<![CDATA[Pharma — April 2023]]>Could This Drug News Lift AbbVie's Stock? https://www.proinvestor.com/investornyt/962700/could-this-drug-news-lift-abbvies-stock

]]>https://dev.proinvestor.com/forum/topic/400873/pharma-april-2023RSS for NodeSun, 07 Jun 2026 02:28:00 GMTSat, 01 Apr 2023 11:38:54 GMT60<![CDATA[Reply to Pharma — April 2023 on Sun, 30 Apr 2023 09:10:19 GMT]]>AbbVie's Blockbuster Is Falling Fast. Time to Sell? https://www.proinvestor.com/investornyt/976509/abbvies-blockbuster-is-falling-fast-time-to-sell

]]>https://dev.proinvestor.com/forum/post/8037781https://dev.proinvestor.com/forum/post/8037781Sun, 30 Apr 2023 09:10:19 GMT<![CDATA[Reply to Pharma — April 2023 on Sun, 30 Apr 2023 05:04:54 GMT]]>Will Pfizer Stock See Higher Levels Post Q1 Earnings? https://www.proinvestor.com/investornyt/976496/will-pfizer-stock-see-higher-levels-post-q1-earnings

]]>https://dev.proinvestor.com/forum/post/8037785https://dev.proinvestor.com/forum/post/8037785Sun, 30 Apr 2023 05:04:54 GMT<![CDATA[Reply to Pharma — April 2023 on Sat, 29 Apr 2023 13:30:32 GMT]]>1 No-Brainer Pharma Stock to Buy With $1,000 Right Now
https://www.proinvestor.com/investornyt/976450/1-no-brainer-pharma-stock-to-buy-with-1000-right-now

]]>https://dev.proinvestor.com/forum/post/8037782https://dev.proinvestor.com/forum/post/8037782Sat, 29 Apr 2023 13:30:32 GMT<![CDATA[Reply to Pharma — April 2023 on Sat, 29 Apr 2023 10:44:29 GMT]]>HC Wainwright & Co. Maintains ASLAN Pharmaceuticals Ltd - ADR (ASLN) Buy Recommendation https://www.proinvestor.com/investornyt/976415/hc-wainwright-amp-co-maintains-aslan-pharmaceuticals-ltd-adr-asln-buy-recommendation

]]>https://dev.proinvestor.com/forum/post/8037779https://dev.proinvestor.com/forum/post/8037779Sat, 29 Apr 2023 10:44:29 GMT<![CDATA[Reply to Pharma — April 2023 on Sat, 29 Apr 2023 10:44:02 GMT]]>Cantor Fitzgerald Maintains Ascendis Pharma A (ASND) Overweight Recommendation https://www.proinvestor.com/investornyt/976414/cantor-fitzgerald-maintains-ascendis-pharma-a-asnd-overweight-recommendation

]]>https://dev.proinvestor.com/forum/post/8037784https://dev.proinvestor.com/forum/post/8037784Sat, 29 Apr 2023 10:44:02 GMT<![CDATA[Reply to Pharma — April 2023 on Sat, 29 Apr 2023 10:43:15 GMT]]>Morgan Stanley Maintains Ascendis Pharma A (ASND) Equal-Weight Recommendation https://www.proinvestor.com/investornyt/976413/morgan-stanley-maintains-ascendis-pharma-a-asnd-equal-weight-recommendation

]]>https://dev.proinvestor.com/forum/post/8037775https://dev.proinvestor.com/forum/post/8037775Sat, 29 Apr 2023 10:43:15 GMT<![CDATA[Reply to Pharma — April 2023 on Sat, 29 Apr 2023 10:42:41 GMT]]>Credit Suisse Maintains Ascendis Pharma A (ASND) Neutral Recommendation https://www.proinvestor.com/investornyt/976412/credit-suisse-maintains-ascendis-pharma-a-asnd-neutral-recommendation

]]>https://dev.proinvestor.com/forum/post/8037783https://dev.proinvestor.com/forum/post/8037783Sat, 29 Apr 2023 10:42:41 GMT<![CDATA[Reply to Pharma — April 2023 on Sat, 29 Apr 2023 02:45:22 GMT]]>JP Morgan Maintains Eli Lilly And (LLY) Overweight Recommendation https://www.proinvestor.com/investornyt/976278/jp-morgan-maintains-eli-lilly-and-lly-overweight-recommendation

]]>https://dev.proinvestor.com/forum/post/8037777https://dev.proinvestor.com/forum/post/8037777Sat, 29 Apr 2023 02:45:22 GMT<![CDATA[Reply to Pharma — April 2023 on Fri, 28 Apr 2023 06:10:53 GMT]]>Lundbeck og partner får FDA-godkendelse til skizofrenimiddel https://www.proinvestor.com/investornyt/975561/lundbeck-og-partner-far-fda-godkendelse-til-skizofrenimiddel

]]>https://dev.proinvestor.com/forum/post/8037774https://dev.proinvestor.com/forum/post/8037774Fri, 28 Apr 2023 06:10:53 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 13:02:20 GMT]]>Is This Big Pharma Stock a Buy for Dividend Investors? https://www.proinvestor.com/investornyt/974944/is-this-big-pharma-stock-a-buy-for-dividend-investors

]]>https://dev.proinvestor.com/forum/post/8037780https://dev.proinvestor.com/forum/post/8037780Thu, 27 Apr 2023 13:02:20 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 11:41:16 GMT]]>Kort video - Pharma og biotek-opdatering UGE 17: Demant ' GN Store Nord ' Novo Nordisk ' Genmab ' Zealand Pharma ' Hansa Biopharma https://www.proinvestor.com/boards/112327

]]>https://dev.proinvestor.com/forum/post/8037778https://dev.proinvestor.com/forum/post/8037778Thu, 27 Apr 2023 11:41:16 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 09:49:13 GMT]]>Eli Lilly stiger efter opjustering trods svagere end ventet indtjening https://www.proinvestor.com/investornyt/974781/eli-lilly-stiger-efter-opjustering-trods-svagere-end-ventet-indtjening

]]>https://dev.proinvestor.com/forum/post/8037771https://dev.proinvestor.com/forum/post/8037771Thu, 27 Apr 2023 09:49:13 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 06:15:45 GMT]]>Vabysmo leads growth in Roche's pharma unit during Q1 https://firstwordpharma.com/story/5732193?aid=5732193

]]>https://dev.proinvestor.com/forum/post/8037773https://dev.proinvestor.com/forum/post/8037773Thu, 27 Apr 2023 06:15:45 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 06:15:03 GMT]]>GSK backs full-year view as Q1 sales slip, but top forecasts
https://firstwordpharma.com/story/5732233?nle=113791&aid=5732233&nlc=30

]]>https://dev.proinvestor.com/forum/post/8037770https://dev.proinvestor.com/forum/post/8037770Thu, 27 Apr 2023 06:15:03 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 06:14:10 GMT]]>Novartis tees up filings for iptacopan in PNH after detailing second study win https://firstwordpharma.com/story/5732247?nle=113791&aid=5732247&nlc=30

]]>https://dev.proinvestor.com/forum/post/8037767https://dev.proinvestor.com/forum/post/8037767Thu, 27 Apr 2023 06:14:10 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 06:13:40 GMT]]>Orbital bags $270 million to advance RNA-based therapeutics https://firstwordpharma.com/story/5732256?nle=113791&aid=5732256&nlc=30

]]>https://dev.proinvestor.com/forum/post/8037776https://dev.proinvestor.com/forum/post/8037776Thu, 27 Apr 2023 06:13:40 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 06:13:00 GMT]]>FDA staff flag concerns over broad use of Lynparza combo in prostate cancer FDA staff flag concerns over broad use of Lynparza combo in prostate cancer

]]>https://dev.proinvestor.com/forum/post/8037766https://dev.proinvestor.com/forum/post/8037766Thu, 27 Apr 2023 06:13:00 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 06:02:20 GMT]]>GSK's Respiratory Syncytial Virus Older Adult Vaccine Candidate Gets Positive CHMP Opinion https://www.proinvestor.com/investornyt/974665/gsks-respiratory-syncytial-virus-older-adult-vaccine-candidate-gets-positive-chmp-opinion

]]>https://dev.proinvestor.com/forum/post/8037768https://dev.proinvestor.com/forum/post/8037768Thu, 27 Apr 2023 06:02:20 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 06:01:21 GMT]]>AstraZeneca Q1 Core Profit Rises, Revenue Ex COVID-19 Up 15% At CER; Reiterates FY23 Guidance https://www.proinvestor.com/investornyt/974670/astrazeneca-q1-core-profit-rises-revenue-ex-covid-19-up-15-at-cer-reiterates-fy23-guidance

]]>https://dev.proinvestor.com/forum/post/8037769https://dev.proinvestor.com/forum/post/8037769Thu, 27 Apr 2023 06:01:21 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 03:38:58 GMT]]>Nordea hæver kursmålet på Lundbeck We raise our revenue estimates by 1-2% going forward, EBITDA estimates by 2% and EBIT estimates by 3-4% – driven by Rexulti and slightly better operating leverage. Our DCF-derived target price is raised to DKK 44 (41) and we remain buyers of the stock

]]>https://dev.proinvestor.com/forum/post/8037765https://dev.proinvestor.com/forum/post/8037765Thu, 27 Apr 2023 03:38:58 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 02:31:32 GMT]]>Novo-topchef ser EU-forslag som "det dummeste jeg har hørt" https://www.proinvestor.com/investornyt/974134/novo-topchef-ser-eu-forslag-som-det-dummeste-jeg-har-hort

]]>https://dev.proinvestor.com/forum/post/8037761https://dev.proinvestor.com/forum/post/8037761Thu, 27 Apr 2023 02:31:32 GMT<![CDATA[Reply to Pharma — April 2023 on Thu, 27 Apr 2023 02:30:54 GMT]]>Medicinalsektor kritiserer EU-forslag om revision af regulering https://www.proinvestor.com/investornyt/974114/medicinalsektor-kritiserer-eu-forslag-om-revision-af-regulering

]]>https://dev.proinvestor.com/forum/post/8037764https://dev.proinvestor.com/forum/post/8037764Thu, 27 Apr 2023 02:30:54 GMT<![CDATA[Reply to Pharma — April 2023 on Wed, 26 Apr 2023 02:20:58 GMT]]>FDA Grants Accelerated Approval For Biogen's ALS Drug https://www.proinvestor.com/investornyt/973749/fda-grants-accelerated-approval-for-biogens-als-drug

]]>https://dev.proinvestor.com/forum/post/8037760https://dev.proinvestor.com/forum/post/8037760Wed, 26 Apr 2023 02:20:58 GMT<![CDATA[Reply to Pharma — April 2023 on Tue, 25 Apr 2023 05:28:59 GMT]]>Pfizer bags FDA approval for Zavzpret migraine nasal spray https://firstwordpharma.com/story/5714749

]]>https://dev.proinvestor.com/forum/post/8037757https://dev.proinvestor.com/forum/post/8037757Tue, 25 Apr 2023 05:28:59 GMT